Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence.

Explore this paper's citation graph

Summary

Recent evidence supporting a role of serum adiponectin concentrations as a novel risk factor and possible diagnostic marker for obesity-related malignancies, including cancers of the breast, endometrium, colon, and prostate is reviewed.

Type
review
Published
2007-09-01
Cited by
360
References
111
Access
Open access

Keywords

Adiponectin, Prostate cancer, Medicine, Insulin resistance, Internal medicine

References

Cited by

Related papers